Published in Arch Dis Child on April 01, 1993
Why do viruses make infants wheeze? Arch Dis Child (1996) 0.79
Analysis of lower airway inflammation in a rabbit model of acute rhinosinusitis. Indian J Otolaryngol Head Neck Surg (2011) 0.76
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Statistical methods for assessing agreement between two methods of clinical measurement. Lancet (1986) 211.50
Protective effect of antibody to parainfluenza type 1 virus. N Engl J Med (1966) 5.97
The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children. J Pediatr (1973) 4.22
Viruses as precipitants of asthmatic attacks in children. JAMA (1974) 3.30
Respiratory viral infection and wheezy bronchitis in childhood. Thorax (1979) 3.01
The mechanism of appearance of immunoglobulin A in nasal secretions in man. J Clin Invest (1967) 2.45
Viruses as precipitants of asthma symptoms. I. Epidemiology. Clin Exp Allergy (1992) 2.28
The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med (1981) 2.15
A new method for the determination of inulin in plasma and urine. Clin Chim Acta (1957) 2.15
The role of nasal secretion and serum antibody in the rhinovirus common cold. Am J Epidemiol (1966) 2.11
Greater frequency of viral respiratory infections in asthmatic children as compared with their nonasthmatic siblings. J Pediatr (1974) 2.09
Serum immunoglobulin concentrations in preschool children measured by laser nephelometry: reference ranges for IgG, IgA, IgM. J Clin Pathol (1983) 2.04
Protein composition of nasal secretion during respiratory virus infection. Proc Soc Exp Biol Med (1965) 2.03
Respiratory syncytial virus neutralizing activity in nasopharyngeal secretions. J Hyg (Lond) (1970) 1.94
Neutralizing and hemagglutination-inhibiting activity of nasal secretions following experimental human infection with A2 influenza virus. J Immunol (1967) 1.77
Plasma exudation as a first line respiratory mucosal defence. Clin Exp Allergy (1991) 1.52
Changes in IgA and IgG concentrations in nasal secretions prior to the appearance of antibody during viral respiratory infection in man. J Immunol (1970) 1.49
Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children. Antimicrob Agents Chemother (1987) 1.40
The class-specific immunoglobulin composition of fluids obtained from various levels of the canine respiratory tract. J Immunol (1976) 1.40
Circadian and interpersonal variability of IgA in nasal secretions. Ann Otol Rhinol Laryngol (1973) 1.20
ELISA for measurement of secretory IgA distinct from monomeric IgA. J Immunol Methods (1987) 1.16
Diurnal variation of nasal protein concentration. Acta Otolaryngol (1976) 1.08
Role of parainfluenza virus-specific IgE in pathogenesis of croup and wheezing subsequent to infection. J Pediatr (1982) 1.08
Effect of specific humoral immunity and some non-specific factors on resistance of volunteers to respiratory coronavirus infection. J Hyg (Lond) (1985) 1.07
Respiratory infections: their role in airway responsiveness and the pathogenesis of asthma. J Allergy Clin Immunol (1990) 1.06
Pathophysiology of rhinitis. 1. Assessment of the sources of protein in methacholine-induced nasal secretions. Am Rev Respir Dis (1988) 1.03
A comparison of the immunoglobulins IgA, IgG and IgE in nasal secretions from normal and asthmatic children. Clin Exp Immunol (1971) 1.00
Immunoglobulins in nasal secretions of infants. Clin Exp Immunol (1970) 0.89
Measurement of secretion in nasal lavage. Clin Sci (Lond) (1987) 0.87
A prospective study of acute respiratory tract infections among children in a kibbutz: the role of secretory IgA and serum immunoglobulins. J Infect Dis (1977) 0.86
Allergy, respiratory tract infections and bronchial hyperreactivity. Pediatr Infect Dis J (1989) 0.81
Immunoglobulin A in secretions from the lower human respiratory tract. Adv Exp Med Biol (1978) 0.80
Upper respiratory tract secretions: pathophysiology. Eur J Respir Dis Suppl (1987) 0.77
Use of polymerase chain reaction to detect rhinovirus in wheezy infants. Arch Dis Child (1992) 0.77
Bacterial bioluminescence: isolation and genetic analysis of functions from Vibrio fischeri. Cell (1983) 12.68
Flagellar rotation and the mechanism of bacterial motility. Nature (1974) 10.38
Identification of genes and gene products necessary for bacterial bioluminescence. Proc Natl Acad Sci U S A (1984) 8.93
Management of asthma: a consensus statement. Arch Dis Child (1989) 7.04
Genetic analysis of flagellar mutants in Escherichia coli. J Bacteriol (1973) 4.98
Identification of polypeptides necessary for chemotaxis in Escherichia coli. J Bacteriol (1977) 4.84
Characterization of Escherichia coli flagellar mutants that are insensitive to catabolite repression. J Bacteriol (1974) 4.84
Bacterial flagella. Annu Rev Microbiol (1977) 4.77
Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med (1993) 4.58
Regulation of lateral flagella gene transcription in Vibrio parahaemolyticus. J Bacteriol (1986) 4.52
Chemotaxis in Escherichia coli: methylation of che gene products. Proc Natl Acad Sci U S A (1977) 4.34
Recombinational switch for gene expression. Science (1977) 4.31
Nucleotide sequence of the regulatory locus controlling expression of bacterial genes for bioluminescence. Nucleic Acids Res (1987) 4.12
Phase variation: genetic analysis of switching mutants. Cell (1980) 4.05
Operon controlling motility and chemotoxis in E. coli. Nature (1976) 3.95
Flagellar dynamometer controls swarmer cell differentiation of V. parahaemolyticus. Cell (1988) 3.59
Genetic analysis of bacteriophage Mu-induced flagellar mutants in Escherichia coli. J Bacteriol (1973) 3.55
Standardization of exercise tests in asthmatic children. Arch Dis Child (1972) 3.55
The DCC protein and prognosis in colorectal cancer. N Engl J Med (1996) 3.51
Measuring gene expression with light. Science (1985) 3.47
Preventing infant deaths. Br Med J (Clin Res Ed) (1985) 3.45
Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J (2008) 3.36
Long-term trial of disodium cromoglycate and isoprenaline in children with asthma. Br Med J (1972) 3.21
The identification of the mot gene product with Escherichia coli-lambda hybrids. Proc Natl Acad Sci U S A (1976) 3.20
Synthesis of mot and che gene products of Escherichia coli programmed by hybrid ColE1 plasmids in minicells. J Bacteriol (1977) 3.05
Phase variation in Salmonella: genetic analysis of a recombinational switch. Proc Natl Acad Sci U S A (1979) 3.02
Phase variation: evolution of a controlling element. Science (1980) 2.96
Surface-induced swarmer cell differentiation of Vibrio parahaemolyticus. Mol Microbiol (1990) 2.94
Are all wheezing disorders in very young (preschool) children increasing in prevalence? Lancet (2001) 2.90
Non-adherent, low-density cells from human peripheral blood contain dendritic cells and monocytes, both with veiled morphology. Immunology (1986) 2.72
Quantitative measurements of T- and B-cell function in "variable" primary hypogammaglobulinaemia: evidence for a consistent B-cell defect. Clin Exp Immunol (1977) 2.62
Cloning and expression of the flagellar hook gene on hybird plasmids in minicells. Nature (1977) 2.50
Localization of proteins controlling motility and chemotaxis in Escherichia coli. J Bacteriol (1977) 2.47
Genes for the hook-basal body proteins of the flagellar apparatus in Escherichia coli. J Bacteriol (1978) 2.44
Defining the physician's duty to warn: consensus statement of Ontario's Medical Expert Panel on Duty to Inform. CMAJ (1998) 2.42
Diagnosis of acute bacterial pneumonia in Nigerian children. Value of needle aspiration of lung of countercurrent immunoelectrophoresis. Arch Dis Child (1977) 2.42
Bacterial bioluminescence: isolation and expression of the luciferase genes from Vibrio harveyi. Science (1982) 2.38
Characterization of lambda Escherichia coli hybrids carrying chemotaxis genes. J Bacteriol (1977) 2.37
Chronic malabsorption due to cryptosporidiosis in a child with immunoglobulin deficiency. Gut (1982) 2.37
Predictive value of cranial ultrasound in the newborn baby: a reappraisal. Lancet (1985) 2.37
Lung function in children of low birth weight. Arch Dis Child (1989) 2.29
Transposon mutagenesis of marine Vibrio spp. J Bacteriol (1984) 2.29
Circulating catecholamines in exercise and hyperventilation induced asthma. Thorax (1981) 2.22
Identification of the structural gene for the hook subunit protein of Escherichia coli flagella. J Bacteriol (1978) 2.20
Mutations in the DNA ligase I gene of an individual with immunodeficiencies and cellular hypersensitivity to DNA-damaging agents. Cell (1992) 2.13
Identification of a locus controlling expression of luminescence genes in Vibrio harveyi. J Bacteriol (1989) 2.12
Exercise-induced asthma. Br J Dis Chest (1975) 2.10
Hypogammaglobulinaemia associated with gold therapy. Ann Rheum Dis (1984) 2.10
How much aerosol reaches the lungs of wheezy infants and toddlers? Arch Dis Child (1990) 2.07
Further studies on a comprehensive department of psychological medicine. A four-year review of the in-patient case-load. Br J Psychiatry (1968) 2.07
Serum immunoglobulin concentrations in preschool children measured by laser nephelometry: reference ranges for IgG, IgA, IgM. J Clin Pathol (1983) 2.04
Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet (1985) 2.03
Treatment of potentially life-threatening enterovirus infections with pleconaril. Clin Infect Dis (2001) 2.02
Treatment of acute, episodic asthma in preschool children using intermittent high dose inhaled steroids at home. Arch Dis Child (1990) 2.01
The regulation of flagellar formation and function. J Supramol Struct (1974) 2.01
The luxR gene product of Vibrio harveyi is a transcriptional activator of the lux promoter. J Bacteriol (1992) 1.98
Enhanced antibody responses in active chronic hepatitis: relation to HLA-B8 and HLA-B12 and porto-systemic shunting. Lancet (1976) 1.89
Parental understanding of wheeze and its impact on asthma prevalence estimates. Eur Respir J (2006) 1.89
Classification of patients with common variable immunodeficiency by B cell secretion of IgM and IgG in response to anti-IgM and interleukin-2. Clin Immunol Immunopathol (1990) 1.88
Acoustical properties of speech as indicators of depression and suicidal risk. IEEE Trans Biomed Eng (2000) 1.85
Phosphate regulation of gene expression in Vibrio parahaemolyticus. J Bacteriol (1987) 1.80
Chemotactic control of the two flagellar systems of Vibrio parahaemolyticus. J Bacteriol (1990) 1.78
Wheeze and asthma prevalence and related health-service use in white and south Asian pre-schoolchildren in the United Kingdom. Clin Exp Allergy (2007) 1.77
Paradoxical response to nebulised salbutamol in wheezy infants, assessed by partial expiratory flow-volume curves. Thorax (1987) 1.77
Multi-dimensional phenotyping: towards a new taxonomy for airway disease. Clin Exp Allergy (2005) 1.77
Neutrophil apoptosis and clearance from neonatal lungs. Lancet (1991) 1.76
Genetic analysis of Escherichia coli K-12 region I flagellar mutants. J Bacteriol (1977) 1.76
Polyarthritis in adults with hypogammaglobulinaemia and its rapid response to immunoglobulin treatment. Br Med J (1976) 1.75
Demonstration by placebo response in asthma by means of exercise testing. J Psychosom Res (1973) 1.75
The economic impact of preschool asthma and wheeze. Eur Respir J (2003) 1.74
Irregularities and power law distributions in the breathing pattern in preterm and term infants. J Appl Physiol (1985) (1998) 1.72
Increase in interleukin (IL)-1 beta and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity. Pediatr Res (1996) 1.71
Iron regulation of swarmer cell differentiation of Vibrio parahaemolyticus. J Bacteriol (1989) 1.69
Problems of interpreting exercise-induced asthma. J Allergy Clin Immunol (1973) 1.68
Positioning flagellar genes in Escherichia coli by deletion analysis. J Bacteriol (1974) 1.64
Parental education and guided self-management of asthma and wheezing in the pre-school child: a randomised controlled trial. Thorax (2002) 1.61
Failure in antigen responses by T cells from patients with common variable immunodeficiency (CVID). Clin Exp Immunol (1994) 1.61
Dichotomy between immunoglobulin synthesis by cells in gut and blood of patients with hypogammaglobulinaemia. Lancet (1975) 1.60
Respiratory symptoms in children of low birth weight. Arch Dis Child (1989) 1.60
Airway responsiveness in low birthweight children and their mothers. Arch Dis Child (1988) 1.58
Controlled trial of slow-release aminophylline in childhood asthma: are short-term trials valid? Br Med J (Clin Res Ed) (1982) 1.57
Cellular abnormalities in common variable immunodeficiency. Immunodefic Rev (1990) 1.56
Coeliac disease with severe hypogammaglobulinaemia. Gut (1981) 1.55
Intracellular immunoglobulin production in vitro by lymphocytes from patients with hypogammaglobulinaemia and their effect on normal lymphocytes. Clin Exp Immunol (1976) 1.53
The therapy of pre-school wheeze: appropriate and fair? Pediatr Pulmonol (2006) 1.53
Bronchodilators for wheezy infants? Arch Dis Child (1984) 1.53
Identification and function of T cells in the peripheral blood of patients with hypogammaglobulinaemia. Clin Exp Immunol (1974) 1.53
Lymphocyte purine 5'-nucleotidase edficiency in primary hypogammaglobulinaemia. Lancet (1977) 1.52
Nucleotide sequence of IS492, a novel insertion sequence causing variation in extracellular polysaccharide production in the marine bacterium Pseudomonas atlantica. J Bacteriol (1989) 1.52
Glucose transport in the kidney. Biochim Biophys Acta (1976) 1.50
Pulmonary compliance in sick low birthweight infants. How reliable is the measurement of oesophageal pressure? Arch Dis Child (1983) 1.50
Flagellar-phase variation: isolation of the rh1 gene. J Bacteriol (1979) 1.50
Identification of a progenitor of the CTX-M-9 group of extended-spectrum beta-lactamases from Kluyvera georgiana isolated in Guyana. Antimicrob Agents Chemother (2005) 1.50
Non-A, non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulin. Lancet (1984) 1.49
Estrogen treatment down-regulates TNF-alpha production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice. J Immunol (2001) 1.48
Common variable immunodeficiency: how many diseases? Immunol Today (1997) 1.48
Metabolic and ventilatory changes in asthmatic patients during and after exercise. Thorax (1972) 1.48
Time course of effect of disodium cromoglycate on exercise-induced asthma. Arch Dis Child (1972) 1.46
Escherichia coli antibody: a screening test for immunodeficiency. Br Med J (1974) 1.46
Duplicate publication and related problems. Pediatrics (1990) 1.46